SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-003837
Filing Date
2023-02-07
Accepted
2023-02-07 16:08:12
Documents
15
Period of Report
2023-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53706
2 ex4-1.htm EX-4.1 51046
3 ex4-2.htm EX-4.2 129425
4 ex10-1.htm EX-10.1 197606
  Complete submission text file 0001493152-23-003837.txt   686392

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrzm-20230207.xsd EX-101.SCH 3227
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrzm-20230207_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrzm-20230207_pre.xml EX-101.PRE 22359
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3382
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 23595132
SIC: 2834 Pharmaceutical Preparations